期刊文献+

CD40-CD40L信号通路与急性冠脉综合征相关性研究进展

Research Progress on Relationship between CD40-CD40L Signal Pathway and Acute Coronary Syndrome
下载PDF
导出
摘要 CD40及其免疫调节配体CD40L是一对互补跨膜糖蛋白,分别属于神经生长因子受体(NGFR)/肿瘤坏死因子受体(TNF-R)超家族和肿瘤坏死因子(TNF)超家族成员,参与许多疾病的发生发展过程。研究发现,CD40-CD40L通路不仅与免疫性疾病(自身免疫性疾病和免疫缺陷病)的发展进程密切相关,同时还介导炎症反应,几乎贯穿急性冠状动脉综合征(acute coronary syndrome, ACS)全过程。现就CD40-CD40L通路与急性冠脉综合征的相关性做一简要概述,以期进一步为探讨CD40-CD40L通路与心血管疾病的预防、治疗提供理论依据。 CD40 and its immunoregulatory ligand (CD40L) are a pair of complementary transmembrane glycoproteins belonging to the nerve growth factor receptor (NGFR)/tumor necrosis factor receptor (TNF-R) superfamily and tumor necrosis factor (TNF) superfamily respectively and participate in the occurrence and development of many diseases. It has been found that CD40-CD40L signal pathway is not only closely related to the development of immune diseases (autoimmune and immune deficiency diseases), but also mediates inflammatory response, almost throughout the whole process of acute coronary syndrome (ACS). In this paper, the interactions between CD40- CD40L pathway and acute coronary syndrome were briefly summarized, to provide more theoretical basis for CD40-CD40L signal pathway and prevention and treatment of cardiovascular diseases.
出处 《临床医学进展》 2020年第11期2493-2498,共6页 Advances in Clinical Medicine
关键词 急性冠脉综合征 CD40-CD40L信号通路 研究进展 Acute Coronary Syndrome CD40-CD40L Signal Pathway Research Progress
  • 相关文献

参考文献10

二级参考文献114

  • 1张莉峰,刘运海,杨期东,刘青芳.急性脑梗死患者颈动脉粥样硬化斑块的研究[J].卒中与神经疾病,2005,12(3):135-137. 被引量:25
  • 2[1]Ross R.Atherosclerosis-An inflammatory disease[J].N Eng J Med,1999,340(2): 115-126.
  • 3[2]Mach F,Schonbeck U,Sukhova GK,et al.Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: Implication for CD40-CD40 ligand signaling in atherosclerosis[J]. Proc Natl Acad Sci USA, 1997, 94(15): 1931-1936.
  • 4[3]Mach F, Schonbeck U, Fabunmi RP,et al. T lymphocytes induce endothelial cell matrix metalloproteinase expression by a CD40L-dependent mechanism: implications for tubule formation[J]. Am J Pathol, 1999, 154(1):229-238.
  • 5[4]Filippo C, Luigi MB, Antonion B, et al. Role of inflammation in the pathogenesis of unstable coronaty artery disease[J]. Am J Cardiol,1997,80(5A):10-16.
  • 6[5]Schonbeck U, Sukhova GK, Shimizu K, et al. Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice[J]. Proc Natl Acad Sci USA, 2000, 97(35): 7458-7463.
  • 7[6]Lutgens E, Cleutjens KB, Heeneman S, et al. Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype[J]. Proc Natl Acad Sci USA, 2000, 97(13): 7464-7469.
  • 8[7]Lee Y, Lee WH, Lee SC, et al. CD40L activation in circulating platelets in patients with acute coronary syndrome[J]. Cardiology, 1999, 92(1): 11-16.
  • 9[8]Aukrust P, Muller F, Ueland T, et al. Enhanced levels of soluble and membrane-bound Cd40 ligand in patients with unstable angina-possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndrome[J]. Circulation, 1999, 100(6): 614-620.
  • 10[9]Kotowicz K, Dixon GL, Klein NJ, et al. Biological function of CD40 on human endothelial cells: costimulation with CD40 ligand and interleukin-4 selectively induces expression of vascular cell adhesion molecule-1 and P-selectin resulting in preferential adhesion of lymphocyte[J]. Immunology, 2001, 100(3): 441-441.

共引文献134

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部